myelomasociety.org
Jun 28, 2025, 06:48
Sundar Jagannath Shares Long-Term CARTITUDE-1 Results on CAR T-Cell Therapy for Multiple Myeloma – Mount Sinai Department of Medicine
Mount Sinai Department of Medicine shared on LinkedIn:
“Sundar Jagannath shares long-term results from the CARTITUDE-1 study, demonstrating the potential for durable remission and improved survival in patients with relapsed or refractory multiple myeloma receiving CAR T-cell therapy.”
An impactful insight about Multiple Myeloma.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 19, 2025, 20:58
Jul 19, 2025, 20:26
Jul 19, 2025, 20:21
Jul 19, 2025, 20:00
Jul 19, 2025, 19:47